OR WAIT null SECS
October 02, 2010
Public-private R&D partnerships are on the rise across Europe, but national goals and academia-industry competition could prevent their success at the European level.
A look at MVI's malaria work in developing countries.
October 01, 2010
The early part of the decade saw a decline in vaccine sales and manufacture, but finally the industry is bouncing back, with Europe particularly well placed to make an impact.
September 02, 2010
A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.
August 02, 2010
Manufacturers and regulators on both sides of the ocean move to ensure the safety of heparin and other globally distributed drug products.
July 02, 2010
As generic divisions become the most-wanted acquisitions of Big Pharma, India's domestic industry may be thinning out.
June 02, 2010
Europe moves to place excipient GMP and GDP standards on the same level as active pharmaceutical ingredients.
June 01, 2010
Despite being a historically strong performer in the pharmaceutical arena, Germany is now underperforming compared with the growth of other European markets.
May 02, 2010
The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?
April 02, 2010
As demand for global vaccine development and production grows, all eyes are turning to Asia.